Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Gait Posture ; 97: 40-42, 2022 09.
Article in English | MEDLINE | ID: mdl-35872481

ABSTRACT

BACKGROUND: People with Parkinson's disease (PwPD) showed impairments of balance control which can be aggravated by the presence of higher interlateral postural asymmetry caused by a distinct dopaminergic loss in the substantia nigra between cerebral hemispheres. RESEARCH QUESTION: We evaluate asymmetries between the more and the less affected leg in PwPD in responses to unanticipated stance perturbations. METHODS: Sixteen 16 PwPD participated in the experiment that consisted of recovering a stable upright stance, keeping the feet in place, in response to a perturbation caused by a sudden release of a load equivalent to 7 % of the participant's body mass. Anterior displacement and velocity of the center of pressure (CoP), the latency of gastrocnemius medialis muscle (GM) activation onset, rate of GM activation, and normalized magnitude of muscular activation were analyzed. RESULTS: Analysis revealed significantly rate (p = 0.04) and magnitude (p = 0.02) higher activation of GM in the less affected limb. No significant effects of the leg were found for GM activation latency or CoP-related variables. SIGNIFICANCE: There is a higher contribution of the less affected leg in automatic postural responses in PwPD.


Subject(s)
Parkinson Disease , Posture , Foot/physiology , Humans , Leg/physiology , Muscle, Skeletal/physiology , Postural Balance/physiology , Posture/physiology
2.
J Gerontol A Biol Sci Med Sci ; 76(4): 561-567, 2021 03 31.
Article in English | MEDLINE | ID: mdl-32674140

ABSTRACT

Parkinson's disease (PD) is often classified into tremor dominant (TD) and postural instability gait disorder (PIGD) subtypes. Degeneration of subcortical/cortical pathways is different between PD subtypes, which leads to differences in motor behavior. However, the influence of PD subtype on cortical activity during walking remains poorly understood. Therefore, we aimed to investigate the influence of PD motor subtypes on cortical activity during unobstructed walking and obstacle avoidance. Seventeen PIGD and 19 TD patients performed unobstructed walking and obstacle avoidance conditions. Brain activity was measured using a mobile functional near-infrared spectroscopy-electroencephalography (EEG) systems, and gait parameters were analyzed using an electronic carpet. Concentrations of oxygenated hemoglobin (HbO2) of the prefrontal cortex (PFC) and EEG absolute power from alpha, beta, and gamma bands in FCz, Cz, CPz, and Oz channels were calculated. These EEG channels correspond to supplementary motor area, primary motor cortex, posterior parietal cortex, and visual cortex, respectively. Postural instability gait disorder patients presented higher PFC activity than TD patients, regardless of the walking condition. Tremor dominant patients presented reduced beta power in the Cz channel during obstacle avoidance compared to unobstructed walking. Both TD and PIGD patients decreased alpha and beta power in the FCz and CPz channels. In conclusion, PIGD patients need to recruit additional cognitive resources from the PFC for walking. Both TD and PIGD patients presented changes in the activation of brain areas related to motor/sensorimotor areas in order to maintain balance control during obstacle avoidance, being that TD patients presented further changes in the motor area (Cz channel) to avoid obstacles.


Subject(s)
Gait Disorders, Neurologic , Oxyhemoglobins/analysis , Parkinson Disease , Postural Balance/physiology , Prefrontal Cortex , Tremor , Aged , Electroencephalography/methods , Functional Neuroimaging/methods , Gait Analysis/methods , Gait Disorders, Neurologic/metabolism , Gait Disorders, Neurologic/physiopathology , Humans , Parkinson Disease/classification , Parkinson Disease/metabolism , Parkinson Disease/physiopathology , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Spectroscopy, Near-Infrared/methods , Tremor/metabolism , Tremor/physiopathology , Walking/physiology , Walking/psychology
3.
Neurorehabil Neural Repair ; 34(7): 589-599, 2020 07.
Article in English | MEDLINE | ID: mdl-32449460

ABSTRACT

Background. Although dopaminergic medication improves dual task walking in people with Parkinson disease (PD), the underlying neural mechanisms are not yet fully understood. As prefrontal cognitive resources are involved in dual task walking, evaluation of the prefrontal cortex (PFC) is required. Objective. To investigate the effect of dopaminergic medication on PFC activity and gait parameters during dual task walking in people with PD. Methods. A total of 20 individuals with PD (69.8 ± 5.9 years) and 30 healthy older people (68.0 ± 5.6 years) performed 2 walking conditions: single and dual task (walking while performing a digit vigilance task). A mobile functional near infrared spectroscopy system and an electronic sensor carpet were used to analyze PFC activation and gait parameters, respectively. Relative concentrations of oxygenated hemoglobin (HbO2) from the left and right PFC were measured. Results. People with PD in the off state did not present changes in HbO2 level in the left PFC across walking conditions. In contrast, in the on state, they presented increased HbO2 levels during dual task compared with single task. Regardless of medication state, people with PD presented increased HbO2 levels in the right PFC during dual task walking compared with single task. The control group demonstrated increased PFC activity in both hemispheres during dual task compared with single task. People with PD showed increases in both step length and velocity in the on state compared with the off state. Conclusions. PD limits the activation of the left PFC during dual task walking, and dopaminergic medication facilitates its recruitment.


Subject(s)
Dopamine Agents/pharmacology , Executive Function/drug effects , Gait/drug effects , Levodopa/pharmacology , Parkinson Disease/drug therapy , Prefrontal Cortex/drug effects , Psychomotor Performance/drug effects , Aged , Executive Function/physiology , Female , Functional Neuroimaging , Gait/physiology , Humans , Male , Middle Aged , Parkinson Disease/physiopathology , Prefrontal Cortex/diagnostic imaging , Prefrontal Cortex/physiopathology , Psychomotor Performance/physiology , Spectroscopy, Near-Infrared
SELECTION OF CITATIONS
SEARCH DETAIL
...